A Phase 2 Study to Evaluate Efficacy and Safety of VX-561 in Subjects Aged 18 Years and Older With Cystic Fibrosis
Completed · Phase 2 · Has a placebo group
Conditions studied: Cystic Fibrosis
In brief
The purpose of this study is to evaluate the efficacy, safety, pharmacodynamic (PD) and pharmacokinetic (PK) effect of VX-561.
Key facts
- Study ID
- NCT03911713
- Run by
- Vertex Pharmaceuticals Incorporated
- People needed
- 77
- Starts
- 2019-04-17
- Expected to finish
- 2020-08-20
- Last updated by the study team
- 2022-01-25
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Alabama at Birmingham — Birmingham, Alabama, United States
- Banner University of Arizona Medical Center — Tucson, Arizona, United States
- Miller Children's Hospital / Long Beach Memorial — Long Beach, California, United States
- UCSF Gateway Medical Center — San Francisco, California, United States
- National Jewish Health — Denver, Colorado, United States
- University of Miami Miller School of Medicine — Miami, Florida, United States
- Central Florida Pulmonary Group, PA — Orlando, Florida, United States
- Indiana University — Indianapolis, Indiana, United States
- University of Kansas Medical Center — Kansas City, Kansas, United States
- University of Kentucky — Lexington, Kentucky, United States
- Johns Hopkins Hospital — Baltimore, Maryland, United States
- Massachusetts General Hospital Cystic Fibrosis Center Clinical Research Center — Boston, Massachusetts, United States
- Boston Children's Hospital — Boston, Massachusetts, United States
- Michigan Medicine — Ann Arbor, Michigan, United States
- University of Minnesota — Minneapolis, Minnesota, United States
- Cardinal Glennon Children's Hospital — St Louis, Missouri, United States
- Washington University School of Medicine / St. Louis Children's Hospital — St Louis, Missouri, United States
- Dartmouth Hitchcock Medical Center — Lebanon, New Hampshire, United States
- Columbia University Medical Center — New York, New York, United States
- University of North Carolina Hospitals — Chapel Hill, North Carolina, United States
- UC Health Holmes — Cincinnati, Ohio, United States
- ProMedica Toledo Hospital/Toledo Children's Hospital/Pediatric Pulmonary & Cystic Fibrosis Center — Toledo, Ohio, United States
- University of Oklahoma Health Sciences Center — Oklahoma City, Oklahoma, United States
- Children's Hospital of Philadelphia — Philadelphia, Pennsylvania, United States
- Children's Hospital of Pittsburgh of UPMC — Pittsburgh, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.